id: pharmacotherapy_access_aud_to_alcohol_use_disorder_recovery
name: Access to Evidence-Based Pharmacotherapy for Alcohol Use Disorder â†’ Alcohol
  Use Disorder Treatment Outcomes
from_node:
  node_id: pharmacotherapy_access_aud
  node_name: Access to Evidence-Based Pharmacotherapy for Alcohol Use Disorder
to_node:
  node_id: alcohol_use_disorder_recovery
  node_name: Alcohol Use Disorder Treatment Outcomes
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Availability of novel pharmacotherapeutic options (such as psilocybin-assisted
  therapy) expands treatment choices beyond traditional approaches'
- 'Step 2: Patients who have not responded to conventional treatments (naltrexone,
  acamprosate, disulfiram) gain access to alternative mechanisms of action'
- 'Step 3: Increased treatment options improve patient-treatment matching based on
  individual needs and preferences'
- 'Step 4: Greater engagement and retention in treatment leads to improved drinking
  outcomes and sustained recovery'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: M. Bogenschutz et al. 2022. "Percentage of Heavy Drinking Days
    Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult
    Patients With Alcohol Use Disorder." *JAMA psychiatry*. https://doi.org/10.1001/jamapsychiatry.2022.2096
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.668298'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: regulatory_legal_framework
  direction: strengthens
  strength: strong
  description: Legal status of psilocybin and regulatory approval for therapeutic
    use determines whether this pharmacotherapy is accessible in specific jurisdictions
- name: healthcare_insurance_coverage
  direction: strengthens
  strength: strong
  description: Insurance coverage policies determine affordability and economic accessibility
    of this specialized treatment approach
- name: specialized_treatment_infrastructure
  direction: strengthens
  strength: moderate
  description: Availability of trained therapists and appropriate clinical settings
    for psilocybin administration affects population-level access
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/pharmacotherapy_access_aud_to_alcohol_use_disorder_recovery.yaml
_category: healthcare_access
